Due to the high number of inquiries received and the continuous developments regarding the virus, TAG is offering COVID-19 Retainer Packages to businesses concerned with the impact of this outbreak.
Request a quote below or call us: 1-800-401-2239
Updated: May 07, 2020
In case you missed it:
To continue emphasizing the importance of preventive measures, we further discussed the importance of social distancing (not just in the workplace) at home and outside of work.
Using a face mask/face covering protects others from the wearer’s respiratory droplets. As many infected individuals have been found to be asymptomatic, the practice of wearing a face mask/covering is highly encouraged (and mandated by some retailers and other businesses, in some places). Masks, combined with social distancing, are another risk-reducing measure. This week, TAG came out with a new “Why Wear Masks” graphic to demonstrate the protective measures of wearing a mask and social distancing. Graphics are free and downloadable on our COVID-19 Resources page.
The CDC put out new guidance for isolation; extending 7 days of isolation to at least 10 days after illness onset. TAG continues to recommend those who had symptoms of COVID-19 or had a positive COVID-19 test should be tested prior to returning to work if at all possible. Read more on our Tuesday post!
TAG highly encourages implementing a Wellness Questionnaire with Wellness Checks at the workplace. This practice has proven effective in containing coronavirus spread in workplaces. What should you ask? See here.
We’ve started to see some testing companies advertising antibody tests as a potential employee screening tool to detect infected asymptomatic people. These tests claim detection of IgM antibodies can be used to find “those in early stages of infection” and that these tests can be completed in less than 20 minutes for rapid onsite diagnosis. It’s important to recognize that antibody development occurs later in infection and this type of serological testing isn’t recognized by the FDA as a diagnostic test. Therefore, TAG discourages the use of antibody tests as part of your Wellness Screen.
As states (and regions) move down their various paths to reopen, we are all faced with a new phase of decision-making. While we have all mostly crossed through Phase 1, we are now faced with the even more difficult challenges that can be present in Phase 2 and Phase 3. You can read more, here.
the Food Industry
from Friday May 08, 2020
Antibody Tests as a Wellness Screening Tool?
We’ve started to see some testing companies advertising antibody tests as a potential employee screening tool to detect infected asymptomatic people. These tests claim detection of IgM antibodies can be used to find “those in early stages of infection” and that these tests can be completed in less than 20 minutes for rapid onsite diagnosis.
It’s important to recognize that antibody development occurs later in infection and this type of serological testing isn’t recognized by the FDA as a diagnostic test. In mid-April FDA specifically stated:
“However, some test developers have misused the serology test kit notification list to falsely claim their serological tests are FDA approved or authorized. Others have falsely claimed that their tests can diagnose COVID-19. When we become aware of these issues, we have and will continue to take appropriate action against firms making or distributing unvalidated tests or those making false claims, such as issuing Warning Letters requesting that companies stop their unlawful promotion and detaining and refusing fraudulent test kits at the border.”
Developing accurate and rapid point-of-use diagnostic testing will help employers, clinicians, and public health officials identify and isolate help asymptomatic carriers of COVID-19 and limit the risk of transmission. Many companies are attempting to develop this kind of diagnostic test and these tests will need to be both sensitive and specific to minimize the number of false positives and false negatives associated with widescale testing. This will also likely require people to be tested on a fairly frequent basis since their exposure status can change quickly; especially as society beings to “reopen” in the coming weeks and months.
If you or your company is approached and encouraged to consider workplace testing for COVID-19, reach out to TAG to help independently evaluate the risks and benefits of testing programs and technologies.
As of May 09, 2020 (14:50 ET), there are over 3,959,000 cases (>275,000 deaths) worldwide.
Due to the increasing number of cases in the United States, TAG will move from reporting counts per country to focus on the United States, please see here for the data. For further information regarding worldwide numbers, please refer to John Hopkin University’s aggregate map.
Keep up to date with COVID-19:
Please send us any questions, comments, and/or concerns! We are happy to talk with you.
OR call us at 1-800-401-2239
Get the Insights & Guidance You Need!
Learn how TAG can help your company ensure food safety and brand protection.
Contact us today!